Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump administration buffets global trade with tariffs.
Categories:
Related Post
More cities are embracing AI permitting systems. HUD funding is available for them.
Local governments have until July 13 to apply for up to $3 million in grants for…
Jacobs scores $3.3B add-on for LA colleges modernization
The five-year contract extends the Dallas-based contractor’s role in one of the nation’s largest higher…
‘Not just gameday facilities anymore’: A glimpse into modern stadium design
Continued focus on premium offerings has led to an elevated square-foot-to-seat ratio, as teams mull…